Kidney ischemic preconditioning

Current Opinion in Nephrology and Hypertension

Volumn 11, Issue 1, 2002, Pages 43-48

  Bonventre, Joseph V ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; CELL DIFFERENTIATION; CELL PROTECTION; CELL REGENERATION; HUMAN; KIDNEY FUNCTION; KIDNEY ISCHEMIA; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

ANIMALS; HUMANS; ISCHEMIC PRECONDITIONING; RENAL CIRCULATION;

EID: 0036143959     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200201000-00007     Document Type: Review

References (53)

1. Hemodynamic factors in acute renal failure
2. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
3. A pathological and physiological study of the naturally nephropathic kidney of the dog, rendered acutely nephropathic by uranium or by an anesthetic
4. Die immunität im nierenepithelgewebe
5. Experimental study of acquired resistance of the rabbit's renal epithelium to uranyl nitrate
6. The functional and pathological response of the kidney in dogs subjected to a second subcutaneous injection of uranium nitrate
7. Subcutaneous fat necrosis, hemolysis without siderosis and renal tubular atrophy following repeated glycerol injections
8. Resistance to glycerol induced hemoglobinuric acute renal failure
9. Resistance to acute renal failure afforded by prior renal failure: Examination of the role of renal renin content
10. Gentamicin nephrotoxicity I. Degree and permanence of acquired insensitivity
11. Preconditioning with sodium arsenite inhibits apoptotic cell death in rat kidney with ischemia/reperfusion or cyclosporine-induced injuries, the possible role of heat-shock protein 70 as a mediator of ischemic tolerance
12. Acquired resistance to acute renal failure
13. Gentamicin increases renal susceptibility to an acute ischemic insult
14. Responses of the ischemic acute renal failure kidney to additional ischemic events
15. Responses of the normal rat kidney to sequential ischemic events
16. Postischemic proximal tubular resistance to oxidant stress and Ca2+ ionophore-induced attack: Implications for reperfusion injury
17. Post-ischemic acute renal failure protects proximal tubules from O2 deprivation injury, possibly by inducing uremia
18. Obstruction of proximal tubules initiates cytoresistance against hypoxic damage
19. Protective effects of renal ischemic preconditioning and adenosine pretreatment: Role of A1 and A3 receptors
20. Attenuation of reperfusion injury by renal isohaemic preconditioning: The role of nitric oxide
21. Ischaemia-reperfusion injury in the rat kidney: The effect of preconditioning
22. Ischemic preconditioning improves postischemic acute renal failure
23. Ischemic preconditioning attenuates functional, metabolic, and morphologic injury from ischemic acute renal failure in the rat
24. No protection of the porcine kidney by ischaemic preconditioning
25. Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment
26. The cell cycle-regulatory CDC25A phosphatase inhibits apoptosis signal-regulating kinase 1
27. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
28. MAPK activation determines renal epithelial cell survival during oxidative injury
29. Heat-shock protein 25 induction and redistribution during actin reorganization after renal ischemia
30. Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways
31. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required, for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: Glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK
32. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD
33. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways
34. SB 203580, an inhibitor of p38 MAPK, abolishes infarct-limiting effect of ischemic preconditioning in isolated rabbit hearts
35. The role of differential activation of p38- mitogen-activated protein kinase in preconditioned ventricular myocytes
36. Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury: Possible connection to an interleukin-6-dependent pathway
37. Contribution of nitric oxide to the protective effects of ischemic preconditioning in ischemia-reperfused rat kidneys
38. Nitric oxide prevents neutrophil-mediated acute renal failure
39. Tissue content of adenosine, inosine and hypoxanthine in the rat kidney after ischemia and postischemic recirculation
40. A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion
41. Antibody to intercellular adhesion molecule-1 protects the kidney against ischemic injury
42. Intercellular adhesion molecule-1 deficient mice are protected against renal ischemia
43. Protein kinase C and G(i/o) proteins are involved in adenosine- and ischemic preconditioning-mediated renal protection
44. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo
45. ATP channel
46. Prodromal angina limits infarct size: A role for ischemic preconditioning
47. Previous angina alters in-hospital outcome in TIMI 4: A clinical correlate to preconditioning?
48. Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: Retrospective clinical evidence of 'preconditioning'
49. Prospective temporal analysis of the onset of preinfarction angina versus outcome: An ancillary study in TIMI-9B
50. Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty
51. Cardiac ischemic preconditioning improves lung preservation in valve replacement operations